Author

Amna Mohamed

Institutions: University of Technology and Applied Sciences, Muscat, University of Technology and Applied Sciences

Observed institutions: Kingston University London, University of Technology and Applied Sciences, Muscat, Sultan Qaboos Comprehensive Cancer Care & Research Center, University of Technology and Applied Sciences, Egyptian Drug Authority

ORCID: 0009-0003-5835-3167

Observed ORCID: 0009-0003-5835-3167

OpenAlex ID: A5023671276

Suitability of Amoxicillin–Clavulanic Acid for Administration via Prolonged Infusion

2020 · Sarah Fawaz, Breanna Dixon, et al. · Drug Design Development and Therapy · 8

Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: A comprehensive review

2024 · Amna Mohamed, Bushra Salman, et al. · Journal of Oncology Pharmacy Practice · 4

Pharmacist-led interventions in hematological malignancies: a systematic review of clinical, process and economic outcomes

2026 · Amna Mohamed, Bushra Salman, et al. · Frontiers in Pharmacology · 1

Oncology stewardship: A narrative review of principles and practices

2025 · Bushra Salman, Amna Mohamed, et al. · Journal of Oncology Pharmacy Practice · 1

Hydroxyurea Pharmacokinetics and Precision Dosing in Sickle Cell Disease: A Scoping Review

2026 · Amna Mohamed, Jokha Al-Qassabi, et al. · Pharmaceuticals

Effect of Combinations of Sorafenib With Certain Monoclonal Antibodies on Hepg2 Cancer Cell Line

2020 · Amna Mohamed, Alaa Taha, et al. · Journal of Applied Pharmacy

Works count: 6

Citation count: 14

H-index: 2

I10-index: